EX-FILING FEES 8 d811721dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107.1

Calculation of Filing Fee Tables

Form S-3

(Form Type)

Royalty Pharma plc

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

                         
     Security
Type
 

Security

Class

Title

  Fee
Calculation
or Carry
Forward
Rule
  Amount
Registered
(1)
  Proposed
Maximum
Offering
Price Per
Unit(1)
  Maximum
Aggregate
Offering
Price(1)
  Fee
Rate(2)
  Amount of
Registration
Fee(2)
  Carry
Forward
Form
Type
  Carry
Forward
File
Number
  Carry
Forward
Initial
Effective
Date
  Filing Fee
Previously
Paid In
Connection
with Unsold
Securities to
Be Carried
Forward
 
Newly Registered Securities
                         
Fees to Be
Paid
  Equity  

Class A

Ordinary Shares,

nominal

value

$0.0001

per share

 

Rule 456(b)

and Rule

457(r) (2)

                   
                         
    Equity   Preference Shares  

Rule 456(b)

and Rule

457(r) (2)

                   
                         
    Debt   Debt Securities  

Rule 456(b)

and Rule

457(r) (2) 

                   
                         
    Other   Warrants  

Rule 456(b)

and Rule

457(r) (2) 

                   
                         
    Other   Purchase Contracts  

Rule 456(b)

and Rule

457(r) (2) 

                   
                         
    Other   Units  

Rule 456(b)

and Rule

457(r) (2) 

                   
                         
    Other   Guarantees  

Rule 456(b)

and Rule

457(r) (2) 

                   
                         
Fees
Previously
Paid
  N/A   N/A   N/A   N/A   N/A   N/A     N/A          
 
Carry Forward Securities
                         
Carry
Forward
Securities
  N/A   N/A   N/A   N/A     N/A       N/A   N/A   N/A   N/A
                   
    Total Offering Amounts      N/A     N/A          
                   
    Total Fees Previously Paid          N/A          
                   
    Total Fee Offsets          N/A          
                   
    Net Fee Due                N/A                

 

(1)

An indeterminate aggregate initial offering price and number or amount of the securities of each identified class is being registered as may from time to time be issued at indeterminate prices pursuant to this Registration Statement.

(2)

In accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended, Royalty Pharma plc is deferring payment of all of the registration fee. Registration fees will be paid subsequently on a “pay as you go” basis. Royalty Pharma plc will calculate the registration fee applicable to an offer of securities pursuant to this Registration Statement based on the fee payment rate in effect on the date of such fee payment.